Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group
- PMID: 31506250
- DOI: 10.1016/j.euo.2019.08.002
Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group
Abstract
Background: Reports on perioperative complications after postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for nonseminoma germ cell tumour (NSGCT) are from experienced single centres, with a lack of population-based studies.
Objective: To assess the complications of bilateral and unilateral PC-RPLND.
Design, setting, and participants: A prospective, population-based, observational multicentre study included all patients with NSGCT who underwent PC-RPLND in Norway and Sweden during 2007-2014. Of a total of 318 patients, 87 underwent bilateral PC-RPLND and 231 underwent unilateral PC-RPLND. The median follow-up was 6 yr.
Outcome measurements and statistical analysis: Bilateral and unilateral PC-RPLND were compared for the outcomes of intra- and postoperative complications (graded by Clavien-Dindo) and retrograde ejaculation (with or without nerve-sparing surgery). Complications were reported as absolute counts and percentages. The χ2 test was used for comparisons.
Results and limitations: The incidence of intraoperative complications was higher for bilateral PC-RPLND than for unilateral PC-RPLND (14% vs 4.3%, p = 0.003), with ureteral injury as the most frequent reported complication (2% of the patients). Postoperative complications were more common after bilateral than after unilateral PC-RPLND (45% vs 25%, p = 0.001) with Clavien ≥3b reported in 8.3% and 2.2%, respectively (p = 0.009). Lymphatic leakage was the most common complication occurring in 11% of the patients. Retrograde ejaculation occurred more frequently after bilateral than after unilateral surgery (59% vs 32%, p < 0.001). Limitations of the study include reporting of retrograde ejaculation, which was based on a chart review.
Conclusions: Intra- and postoperative complications including retrograde ejaculation are more frequent after bilateral PC-RPLND than after unilateral PC-RPLND.
Patient summary: Lymph node dissection in patients with testicular cancer puts them at risk of complications. In this study, we present the complications after lymph node dissection.
Keywords: Complications; Nonseminoma; Postchemotherapy retroperitoneal lymph node dissection; Retrograde ejaculation; Testicular cancer.
Copyright © 2019 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Comment in
-
Re: Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-Based Study from the Swedish Norwegian Testicular Cancer Group.J Urol. 2020 Jun;203(6):1064. doi: 10.1097/JU.0000000000001001. Epub 2020 Mar 11. J Urol. 2020. PMID: 32159430 No abstract available.
Similar articles
-
Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group.Eur Urol Oncol. 2022 Apr;5(2):235-243. doi: 10.1016/j.euo.2021.02.002. Epub 2021 Mar 6. Eur Urol Oncol. 2022. PMID: 33750683
-
Practice Patterns and Impact of Postchemotherapy Retroperitoneal Lymph Node Dissection on Testicular Cancer Outcomes.Eur Urol Oncol. 2018 Aug;1(3):242-251. doi: 10.1016/j.euo.2018.04.005. Epub 2018 Jun 6. Eur Urol Oncol. 2018. PMID: 31058267 Free PMC article.
-
Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients.J Endourol. 2016 Oct;30(10):1112-1119. doi: 10.1089/end.2016.0458. J Endourol. 2016. PMID: 27533924
-
Major complications of post-chemotherapy retroperitoneal lymph node dissection in a contemporary cohort of patients with testicular cancer and a review of the literature.World J Surg Oncol. 2020 Sep 24;18(1):253. doi: 10.1186/s12957-020-02032-1. World J Surg Oncol. 2020. PMID: 32972425 Free PMC article. Review.
-
Primary and Postchemotherapy Retroperitoneal Lymphadenectomy for Testicular Cancer.Oncol Res Treat. 2018;41(6):370-378. doi: 10.1159/000489508. Epub 2018 May 17. Oncol Res Treat. 2018. PMID: 29772568 Review.
Cited by
-
Unilateral Post-Chemotherapy Robot-Assisted Retroperitoneal Lymph Node Dissection for Stage II Non-Seminomatous Germ Cell Tumors: Sexual and Reproductive Outcomes.Cancers (Basel). 2024 Jun 15;16(12):2231. doi: 10.3390/cancers16122231. Cancers (Basel). 2024. PMID: 38927936 Free PMC article.
-
Robotic-assisted retroperitoneal lymph node dissection for stage II testicular cancer.Asian J Urol. 2024 Jan;11(1):121-127. doi: 10.1016/j.ajur.2022.03.010. Epub 2022 Jul 30. Asian J Urol. 2024. PMID: 38312811 Free PMC article.
-
Robotic retroperitoneal lymph node dissection for testicular cancer at a national referral centre.BJUI Compass. 2022 Mar 31;3(5):363-370. doi: 10.1002/bco2.149. eCollection 2022 Sep. BJUI Compass. 2022. PMID: 35950045 Free PMC article.
-
A meta-analysis of clinicopathologic features that predict necrosis or fibrosis at post-chemotherapy retroperitoneal lymph node dissection in individuals receiving treatment for non-seminoma germ cell tumours.Front Oncol. 2022 Aug 17;12:931509. doi: 10.3389/fonc.2022.931509. eCollection 2022. Front Oncol. 2022. PMID: 36059636 Free PMC article.
-
Additional surgical procedures and perioperative morbidity in post-chemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer in two intermediate volume hospitals.World J Urol. 2021 Mar;39(3):839-846. doi: 10.1007/s00345-020-03229-5. Epub 2020 May 5. World J Urol. 2021. PMID: 32372160 Free PMC article.
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical